行情中心升级到1.1版! 官方博客

基金业绩

基金费率

投资组合

基金概况

财务数据

易方达沪深300医药ETF(512010)

2025-01-27     0.3451-0.0290%
持仓重大变化
截止日期:  
 查询其他基金该项数据
序号 股票代码 股票简称 累计买入金额(万元) 占期初净值比例(%)
1300760迈瑞医疗132,761.036.50
2600161天坛生物45,711.422.24
3300015爱尔眼科39,730.861.94
4300832新产业35,514.751.74
5000538诺安优势行业混合A34,876.491.71
6000538云南白药34,876.491.71
7300122智飞生物29,857.871.46
8000661银华活钱宝货币E26,868.611.31
9000661长春高新26,868.611.31
10603259药明康德25,586.751.25
11002252融通成长30灵活配置混合A/B25,170.911.23
12002252上海莱士25,170.911.23
13002001华夏回报混合A23,532.851.15
14002001新和成23,532.851.15
15300347泰格医药22,935.201.12
16000963兴业多策略混合21,846.281.07
17000963华东医药21,846.281.07
18002821招商丰乐混合A20,776.761.02
19002821凯莱英20,776.761.02
20300142沃森生物18,196.480.89
21300759康龙化成14,706.680.72
22002007工银新得润混合13,274.720.65
23002007华兰生物13,274.720.65
24000999华润三九13,255.670.65
25002603工银瑞丰半年定开纯债债券发起式9,497.190.46
26002603以岭药业9,497.190.46
27300896爱美客5,425.020.27
28688271联影医疗5,315.100.26
序号 股票代码 股票简称 累计卖出金额(万元) 占期初净值比例(%)
1300760迈瑞医疗132,195.896.47
2300015爱尔眼科40,133.941.96
3000538诺安优势行业混合A35,194.851.72
4000538云南白药35,194.851.72
5300122智飞生物30,891.821.51
6000661银华活钱宝货币E26,926.771.32
7000661长春高新26,926.771.32
8002252融通成长30灵活配置混合A/B24,653.751.21
9002252上海莱士24,653.751.21
10688271联影医疗23,714.191.16
11300347泰格医药22,916.571.12
12000963兴业多策略混合21,801.141.07
13000963华东医药21,801.141.07
14002821招商丰乐混合A20,767.681.02
15002821凯莱英20,767.681.02
16300142沃森生物18,356.180.90
17600276恒瑞医药16,551.310.81
18300759康龙化成14,693.140.72
19002001华夏回报混合A14,482.740.71
20002001新和成14,482.740.71
21000999华润三九13,288.320.65
22002007工银新得润混合13,149.440.64
23002007华兰生物13,149.440.64
24002603工银瑞丰半年定开纯债债券发起式9,545.880.47
25002603以岭药业9,545.880.47
26600436片仔癀6,286.700.31
27300896爱美客6,123.530.30
28600196复星医药2,657.070.13